PanDox: Targeted Doxorubicin in Pancreatic Tumours

NCT04852367 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of recruitment

Conditions

Pancreatic Ductal Adenocarcinoma
Pancreatic Cancer Stage IV
Pancreatic Cancer Non-resectable
Pancreatic Cancer Metastatic

Interventions

DEVICE: Focused Ultrasound
DRUG: Doxorubicin
DRUG: ThermoDox

Sponsor

University of Oxford

Collaborators

[object Object]
[object Object]